We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Usutu Virus Infections Found among Austrian Blood Donors

By LabMedica International staff writers
Posted on 24 Oct 2017
Print article
Image: The cobas 8800 fully integrated and automated system for sample preparation and real-time polymerase chain reactions (Photo courtesy of Roche).
Image: The cobas 8800 fully integrated and automated system for sample preparation and real-time polymerase chain reactions (Photo courtesy of Roche).
Usutu virus (USUV) is an African mosquito-borne flavivirus belonging to the Japanese encephalitis virus serocomplex. USUV is closely related to Murray Valley encephalitis virus, Japanese encephalitis virus, and West Nile virus (WNV).

Besides wild birds, humans can also be infected with Usutu virus through mosquito bites. Usually human Usutu virus infections are asymptomatic though occasionally they may result in fever and rash. Neurologic symptoms and severe courses of the disease are rare in humans, although critical illness was reported in immunosuppressed patients.

European scientists led by those at the University of Veterinary Medicine (Vienna, Austria) collected samples of all blood donations collected from June 1, 2017 onwards by the Blood Service for Austrian Red Cross during the ongoing WNV transmission season 2017 and were sent to the German Red Cross, Blood Service for Baden-Württemberg-Hessen. In Germany they were screened in minipools of 19 samples using the automated nucleic acid (NAT) test on the cobas 8800 system.

The investigators reported that as of October 11, 2017, a total of seven of 12,047 blood donations collected between July 24 and August 25, 2017, reacted positive. WNV NAT-screening positive samples were retested by WNV- and Usutu virus (USUV)-specific reverse transcription (RT) - and quantitative reverse transcription polymerase chain (RT-qPCR) assays as well as by conventional RT-PCR tests amplifying a wide range of flaviviruses. While one blood donation was confirmed as containing WNV nucleic acid, the six others were negative by WNV-specific RT-qPCR, but positive by USUV-specific RT-qPCR.

The authors concluded that although USUV is a potential human pathogen, there are no specific regulations on screening blood donations for this virus. According to the general rules, only clinically healthy people are allowed to donate blood. However, the USUV-positive blood donors did not show any symptoms before and after donation. They propose that extension of flavivirus screening of blood donations might be taken into consideration by USUV-endemic European countries.

In order to raise awareness and allow timely actions, they intentionally wrote this paper at this point in time when the WNV and USUV transmission seasons are still ongoing, which, depending on weather conditions, may last in central Europe until the end of October. The study was published in the October 2017 edition of the journal Eurosurveillance.

Related Links:
University of Veterinary Medicine

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more